Pimecrolimus Cream
intended to relieve inflammation associated with skin conditions, applying targeted action to mitigate immune-mediated skin reactions and support barrier recovery.
Strengths: 10 · 30g
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Elidel
- Therapeutic class
Calcineurin Inhibitor
- Pharmacological class
Immunosuppressant
- Contraindications
hypersensitivity to pimecrolimus; netherton syndrome; skin infections
- Minor side effects
application site warmth; application site irritation; erythema
- Moderate side effects
folliculitis; pruritus
- Dosage forms
Cream
- Administration route
Cutaneous use
- Prescription status
POM
- Manufacturer
Meda Pharmaceuticals
- Onset Time
2–4 days
- Duration
Ongoing
- Storage instructions
Store in a cool, dry place.
- Age restrictions
Suitable for use in children from a minimum age per guidance.
Precautions and warnings
avoid prolonged sun and UV exposure; apply only to affected areas; avoid contact with eyes and mucous membranes
Serious side effects
anaphylaxis — requires immediate medical attention; malignancy — requires immediate medical attention
Patient summary
intended to relieve inflammation associated with skin conditions, applying targeted action to mitigate immune-mediated skin reactions and support barrier recovery.
Mechanism of action
A topical calcineurin inhibitor that blocks the activation of T-lymphocytes, preventing the release of inflammatory cytokines and reducing the redness and itching characteristic of dermatitis.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Avoid application to the breast area to prevent ingestion.
Pimecrolimus Cream
intended to relieve inflammation associated with skin conditions, applying targeted action to mitigate immune-mediated skin reactions and support barrier recovery.
Editorial Notes
- Active ingredient(s): Pimecrolimus
- Listed indication(s): Atopic Dermatitis
Usually available as
- 2 tubes - 10 g1245-10-g-17542
- 2 tubes - 30 g1245-30-g-17544